The recreational cannabis market is projected to grow from $2.24 billion in 2025 to $3.32 billion by 2030, with a CAGR of 7.8-8.2%. Growth is driven by increasing legalization, public acceptance, demand for high-THC products, and innovation in premium edibles, beverages, and vape formats. Key players are launching innovative products and pursuing strategic acquisitions to capitalize on expanding market opportunities.

The global functional food and beverage market is projected to reach $438 billion in 2026, with oral pouches and alternative caffeine delivery formats driving growth. Doseology Sciences launched caffeine-based energy pouches under its Feed That Brain brand, while Kraft Heinz introduced the HEINZ KegChup, Tilray Brands expanded spirits distribution in Illinois, Cronos Group launched Lord Jones cannabis in Israel, and USANA Health Sciences reported strong 2025 sales with positive 2026 guidance.

Cronos Group Inc. announced the launch of its Lord Jones premium cannabis brand in Israel, marking a significant expansion of its borderless product strategy. The initial launch includes five premium indoor-grown flower strains available in Israeli pharmacies, with plans for future special edition and limited-run products. The move reflects Cronos' commitment to international growth and building globally recognized cannabis brands.

Cronos Group Inc. announced the launch of its premium Lord Jones cannabis brand in Israel, marking a significant milestone in its cross-border product strategy. The initial launch includes five premium flower strains grown under controlled indoor cultivation, targeting medical cannabis patients in Israel. The expansion reflects Cronos's commitment to responsible international growth and brand excellence.

Altria Group faces declining revenues despite its traditional strategy of raising prices to offset falling smoking rates. While the stock trades at an attractive P/E ratio of 12 with a 6.8% dividend yield, the company's failed investments in e-cigarettes (Juul, NJOY) and cannabis (Cronos Group) have cost billions. With dividend payments consuming most of its free cash flow, the company risks its ability to sustain dividend growth unless it reverses revenue declines.

President Trump is considering rescheduling marijuana from Schedule I to Schedule III, which could potentially remove tax burdens on cannabis businesses and improve their financial prospects.

Tilray Brands experienced a significant stock surge of 27.5% after President Trump suggested potentially reclassifying marijuana from Schedule I to Schedule III, which could expand the cannabis industry's market opportunities.

Cronos Group is acquiring CanAdelaar, the largest cannabis company in the Netherlands' adult-use cannabis pilot program, for $67 million upfront, with potential additional earnouts. The acquisition provides Cronos strategic entry into the European cannabis market and establishes a market leadership position.

Altria offers a high 6.4% dividend yield, but faces significant challenges including declining cigarette volumes, unsuccessful diversification attempts, and strategic missteps that could threaten its long-term dividend sustainability.

Marijuana stocks experienced significant gains after Donald Trump's video promoting hemp-derived CBD benefits and potential marijuana reclassification, with several cannabis companies and ETFs seeing notable price increases.

President Trump posted a video on Truth Social promoting CBD's potential health benefits, suggesting Medicare coverage and potential healthcare system integration. This sparked a significant rally in cannabis stocks, with multiple companies seeing substantial price increases.

Trump Media announced plans to create a new Cronos treasury company, investing up to $6.4 billion in CRO tokens, which has recently seen a 90% price surge. Despite the short-term excitement, the long-term prospects of the cryptocurrency remain uncertain.